Your browser doesn't support javascript.
Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.
Loveday, Emma K; Hain, Kyle S; Kochetkova, Irina; Hedges, Jodi F; Robison, Amanda; Snyder, Deann T; Brumfield, Susan K; Young, Mark J; Jutila, Mark A; Chang, Connie B; Taylor, Matthew P.
  • Loveday EK; Department of Chemical & Biological Engineering, Montana State University, Bozeman, MT 59717, USA.
  • Hain KS; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Kochetkova I; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Hedges JF; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Robison A; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Snyder DT; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Brumfield SK; Department of Plant Science and Plant Pathology, Montana State University; Bozeman, MT 59717, USA.
  • Young MJ; Department of Plant Science and Plant Pathology, Montana State University; Bozeman, MT 59717, USA.
  • Jutila MA; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
  • Chang CB; Department of Chemical & Biological Engineering, Montana State University, Bozeman, MT 59717, USA.
  • Taylor MP; Department of Microbiology & Immunology, Montana State University, Bozeman, MT 59717, USA.
Viruses ; 13(4)2021 03 26.
Article in English | MEDLINE | ID: covidwho-1154536
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2 heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting the destructive effects of inactivation. We observed that 15 min of incubation at 65 °C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 µJ/cm2), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody detection assays. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the quality of resulting viral proteins and virions were differentially impacted depending on inactivation method and time. Here, we outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virion / Disinfection / Virus Inactivation / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: V13040562

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Virion / Disinfection / Virus Inactivation / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: V13040562